Target Price | $35.70 |
Price | $32.66 |
Potential |
9.31%
register free of charge
|
Number of Estimates | 14 |
14 Analysts have issued a price target IMAX Corporation 2026 .
The average IMAX Corporation target price is $35.70.
This is
9.31%
register free of charge
$40.95
25.38%
register free of charge
$18.18
44.34%
register free of charge
|
|
A rating was issued by 18 analysts: 15 Analysts recommend IMAX Corporation to buy, 2 to hold and 1 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the IMAX Corporation stock has an average upside potential 2026 of
9.31%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Million $ | 352.21 | 411.66 |
6.04% | 16.88% | |
EBITDA Margin | 15.22% | 41.69% |
3.53% | 173.95% | |
Net Margin | 7.40% | 16.50% |
9.45% | 123.00% |
14 Analysts have issued a sales forecast IMAX Corporation 2025 . The average IMAX Corporation sales estimate is
This results in the following potential growth metrics:
14 Analysts have issued an IMAX Corporation EBITDA forecast 2025. The average IMAX Corporation EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
13 IMAX Corporation Analysts have issued a net profit forecast 2025. The average IMAX Corporation net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | 0.48 | 1.26 |
4.35% | 162.50% | |
P/E | 25.85 | |
EV/Sales | 4.68 |
13 Analysts have issued a IMAX Corporation forecast for earnings per share. The average IMAX Corporation EPS is
This results in the following potential growth metrics and future valuations:
IMAX Corporation...
Analyst | Rating | Action | Date |
---|---|---|---|
Barrington Research |
Locked
➜
Locked
|
Locked | Sep 19 2025 |
Rosenblatt |
Locked
➜
Locked
|
Locked | Jul 25 2025 |
Wells Fargo |
Locked
➜
Locked
|
Locked | Jul 25 2025 |
Benchmark |
Locked
➜
Locked
|
Locked | Jul 25 2025 |
Wedbush |
Locked
➜
Locked
|
Locked | Jul 25 2025 |
Barrington Research |
Locked
➜
Locked
|
Locked | Jul 24 2025 |
Rosenblatt |
Locked
➜
Locked
|
Locked | Jul 11 2025 |
Analyst Rating | Date |
---|---|
Locked
Barrington Research:
Locked
➜
Locked
|
Sep 19 2025 |
Locked
Rosenblatt:
Locked
➜
Locked
|
Jul 25 2025 |
Locked
Wells Fargo:
Locked
➜
Locked
|
Jul 25 2025 |
Locked
Benchmark:
Locked
➜
Locked
|
Jul 25 2025 |
Locked
Wedbush:
Locked
➜
Locked
|
Jul 25 2025 |
Locked
Barrington Research:
Locked
➜
Locked
|
Jul 24 2025 |
Locked
Rosenblatt:
Locked
➜
Locked
|
Jul 11 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.